Monsanto Co. has been increasingly active during the past two years in consolidating its position in agricultural biotechnology, through corporate acquisitions and alliances, as well as patent litigation.

The basis for these moves is Monsanto's belief, as stated in its 1995 annual report, that biotech will fundamentally change the nature of